Biomarker for diagnosing drug-induced liver injury

摘要

The present invention relates to a biomarker for diagnosing liver damage by a drug, and includes a kit that can diagnose or predict liver damage caused by amoxicillin or clavulanic acid by including a primer complementary to the sequence of miR-122, To a method for providing information to a user.;